Latest Breaking News On - Pentara corporation - Page 1 : comparemela.com

No Decline in Cognition Scores in Patients with Mild Alzheimer s Disease Who Received Simufilam Continuously For 24 Months

ADAS-Cog Scores Were Stable in a Group of Patients with Mild Alzheimer’s Who Received Drug Candidate Simufilam Continuously, Baseline to Month 24.Mild Alzheimer’s Patients Who Received Simufilam.

United statesPuerto ricoSouth koreaRemi barbierEric schoenSuzanne hendrixCassava sciencesPentara corporationA groupGroup of patientsCassava sciences incNational institutes of healthCog scores were stableMild alzheimerGroup averageSimufilam safe

Cassava Sciences (SAVA) Reports No Decline in Cognition Scores in Simufilam Patients with Mild Alzheimer s Disease at 24 Months

Cassava Sciences (SAVA) Reports No Decline in Cognition Scores in Simufilam Patients with Mild Alzheimer s Disease at 24 Months
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPuerto ricoSouth koreaSuzanne hendrixEric schoenRemi barbierCassava sciencesPentara corporationCassava sciences incNational institutes of healthFull analysis setCognition maintenance studyCassava scienceMore information contactChief financialNote regarding forward looking statements

MRI Data Suggest Simufilam is Not Associated with Amyloid-related Imaging Abnormalities (ARIA)

MRI Data Suggest Simufilam is Not Associated with Amyloid-related Imaging Abnormalities (ARIA)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEric schoenSuzanne hendrixPentara corporationCassava sciences incCassava sciencesSafety finding basedKnown risk factorAnti amyloid antibodyCassava scienceClinical trialsWithdrawal studyMild to moderate alzheimerPrimary mechanismFaction confirmedMore information contact

Cassava Sciences (SAVA) Reports MRI Data Suggesting Simufilam is Not Associated with Amyloid-related Imaging Abnormalities (ARIA)

Cassava Sciences (SAVA) Reports MRI Data Suggesting Simufilam is Not Associated with Amyloid-related Imaging Abnormalities (ARIA)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSuzanne hendrixCassava sciences incPentara corporationCassava scienceClinical trialsWithdrawal studyMild to moderate alzheimerPrimary mechanismFaction confirmed

MRI Data Suggest Simufilam is Not Associated with

Safety Finding Based on Blinded MRI Brain Data at Week 40ARIA is a Known Risk Factor for Anti-Amyloid Antibody DrugsMRI Data Presented at the 16th CTAD.

United statesSuzanne hendrixEric schoenCassava sciencesCassava sciences incPentara corporationSafety finding basedKnown risk factorAnti amyloid antibodyCassava scienceClinical trialsWithdrawal studyMild to moderate alzheimerPrimary mechanismFaction confirmedMore information contact